Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, October 21, 2022
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
Glen Santangelo Initiated (TEVA) at Strong Buy and Held Target at $10 on, Oct 21st, 2022
Glen Santangelo of Jefferies, Initiated "Teva Pharmaceutical Industries Limited" (TEVA) at Strong Buy and Held Target at $10 on, Oct 21st, 2022.
Glen has made no other calls on TEVA in the last 4 months.
There are 2 other peers that have a rating on TEVA. Out of the 2 peers that are also analyzing TEVA, 1 agrees with Glen's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Nathan Rich of "Goldman Sachs" Maintained at Hold with Increased Target to $10 on, Tuesday, August 2nd, 2022
This is the rating of the analyst that currently disagrees with Glen
- Jason Gerberry of "B of A Securities" Upgraded from Hold to Strong Buy and Increased Target to $13 on, Friday, August 5th, 2022
